Oxford vaccine team wins £1.4m to develop jab against ‘super gonorrhoea’
positivelysharing
Reading Time: < 1minute
The Oxford University institute behind the AstraZeneca Covid vaccine has been awarded $2 million (£1.4m) to develop a jab against the increasing threat of “super gonorrhoea”. Read More